160 related articles for article (PubMed ID: 32119736)
1. Human megakaryocytic microparticles induce de novo platelet biogenesis in a wild-type murine model.
Escobar C; Kao CY; Das S; Papoutsakis ET
Blood Adv; 2020 Mar; 4(5):804-814. PubMed ID: 32119736
[TBL] [Abstract][Full Text] [Related]
2. How do megakaryocytic microparticles target and deliver cargo to alter the fate of hematopoietic stem cells?
Jiang J; Kao CY; Papoutsakis ET
J Control Release; 2017 Feb; 247():1-18. PubMed ID: 28024915
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.
Ahmed N; Khokher MA; Hassan HT
Stem Cells; 1999; 17(2):92-9. PubMed ID: 10195569
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
5. Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis.
Luff SA; Kao CY; Papoutsakis ET
PLoS One; 2018; 13(9):e0203991. PubMed ID: 30231080
[TBL] [Abstract][Full Text] [Related]
6. Shear enhances thrombopoiesis and formation of microparticles that induce megakaryocytic differentiation of stem cells.
Jiang J; Woulfe DS; Papoutsakis ET
Blood; 2014 Sep; 124(13):2094-103. PubMed ID: 24948658
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Megakaryocytes Induced from Hematopoietic Stem Cells in Murine and Nonhuman Primate Models.
Guan X; Qin M; Zhang Y; Wang Y; Shen B; Ren Z; Ding X; Dai W; Jiang Y
Stem Cells Transl Med; 2017 Mar; 6(3):897-909. PubMed ID: 28297572
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
9. Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice.
Chang M; Qian JX; Lee SM; Joubran J; Fernandez G; Nichols J; Knoppel A; Buzby JS
Blood; 1999 Apr; 93(8):2515-24. PubMed ID: 10194430
[TBL] [Abstract][Full Text] [Related]
10. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
[TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
Cheng L; Qasba P; Vanguri P; Thiede MA
J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
[TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes.
Pietrzyk-Nivau A; Poirault-Chassac S; Gandrille S; Derkaoui SM; Kauskot A; Letourneur D; Le Visage C; Baruch D
PLoS One; 2015; 10(8):e0136652. PubMed ID: 26313154
[TBL] [Abstract][Full Text] [Related]
13. An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis.
Deng B; Banu N; Malloy B; Hass P; Wang JF; Cavacini L; Eaton D; Avraham H
Blood; 1998 Sep; 92(6):1981-8. PubMed ID: 9731056
[TBL] [Abstract][Full Text] [Related]
14. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
15. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.
Liu Y; Wang Y; Gao Y; Forbes JA; Qayyum R; Becker L; Cheng L; Wang ZZ
Stem Cells Transl Med; 2015 Apr; 4(4):309-19. PubMed ID: 25713465
[TBL] [Abstract][Full Text] [Related]
16. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive low-level laser therapy for thrombocytopenia.
Zhang Q; Dong T; Li P; Wu MX
Sci Transl Med; 2016 Jul; 8(349):349ra101. PubMed ID: 27464749
[TBL] [Abstract][Full Text] [Related]
18. Enhanced generation of megakaryocytes from umbilical cord blood-derived CD34(+) cells expanded in the presence of two nutraceuticals, docosahexanoic acid and arachidonic acid, as supplements to the cytokine-containing medium.
Siddiqui NF; Shabrani NC; Kale VP; Limaye LS
Cytotherapy; 2011 Jan; 13(1):114-28. PubMed ID: 20230224
[TBL] [Abstract][Full Text] [Related]
19. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
20. Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production.
Perez LE; Rinder HM; Wang C; Tracey JB; Maun N; Krause DS
Blood; 2001 Mar; 97(6):1635-43. PubMed ID: 11238102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
